Fernando Martinez to Kidney Transplantation
This is a "connection" page, showing publications Fernando Martinez has written about Kidney Transplantation.
Connection Strength
1.556
-
Martinez F, Kamar N, Pallet N, Lang P, Durrbach A, Lebranchu Y, Adem A, Barbier S, Cassuto-Viguier E, Glowaki F, Le Meur Y, Rostaing L, Legendre C, Hermine O, Choukroun G. High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF Study. Am J Transplant. 2010 Jul; 10(7):1695-700.
Score: 0.282
-
Canaud G, Zuber J, Sberro R, Royale V, Anglicheau D, Snanoudj R, Gaha K, Thervet E, Lefr?re F, Cavazzana-Calvo M, No?l LH, M?jean A, Legendre Ch, Martinez F. Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: a pilot study. Am J Transplant. 2009 May; 9(5):1081-6.
Score: 0.258
-
Scemla A, Gerber S, Duquesne A, Parize P, Martinez F, Anglicheau D, Snanoudj R, Zuber M, Bougnoux ME, Legendre C, Lortholary O. Dramatic improvement of severe cryptococcosis-induced immune reconstitution syndrome with adalimumab in a renal transplant recipient. Am J Transplant. 2015 Feb; 15(2):560-4.
Score: 0.097
-
Aubert O, Bories MC, Suberbielle C, Snanoudj R, Anglicheau D, Rabant M, Martinez F, Scemla A, Legendre C, Sberro-Soussan R. Risk of antibody-mediated rejection in kidney transplant recipients with anti-HLA-C donor-specific antibodies. Am J Transplant. 2014 Jun; 14(6):1439-45.
Score: 0.092
-
Pallet N, Rabant M, Legendre C, Martinez F, Choukroun G. The nephroprotective properties of recombinant human erythropoietin in kidney transplantation: experimental facts and clinical proofs. Am J Transplant. 2012 Dec; 12(12):3184-90.
Score: 0.083
-
Servais A, Meas-Yedid V, No?l LH, Martinez F, Panterne C, Kreis H, Zuber J, Timsit MO, Legendre Ch, Olivo-Marin JC, Thervet E. Interstitial fibrosis evolution on early sequential screening renal allograft biopsies using quantitative image analysis. Am J Transplant. 2011 Jul; 11(7):1456-63.
Score: 0.075
-
Canaud G, Bienaim? F, No?l LH, Royal V, Alyanakian MA, Dautzenberg MD, Rabant M, Posson J, Thervet E, Anglicheau D, Kreis H, Martinez F, Legendre C, Zuber J. Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodies. Am J Transplant. 2010 Sep; 10(9):2051-60.
Score: 0.071
-
Sberro-Soussan R, Zuber J, Suberbielle-Boissel C, Candon S, Martinez F, Snanoudj R, Rabant M, Pallet N, Nochy D, Anglicheau D, Leruez M, Loupy A, Thervet E, Hermine O, Legendre C. Bortezomib as the sole post-renal transplantation desensitization agent does not decrease donor-specific anti-HLA antibodies. Am J Transplant. 2010 Mar; 10(3):681-6.
Score: 0.069
-
Legendre Ch, Kreis H, Martinez F, Snanoudj R, Mamzer MF, Sberro R, Bererhi L, Anglicheau D, Zuber J, Loupy A, Thervet E, Pallet N, Sartorius A, Bertrand D, Canaud G, No?l LH, Rabant M, Timsit MO, M?jean A. Kidney transplantation at Necker Hospital: the most recent 5-year period (2004-2009). Clin Transpl. 2010; 127-32.
Score: 0.068
-
Snanoudj R, Rabant M, Timsit MO, Karras A, Savoye E, Tricot L, Loupy A, Hiesse C, Zuber J, Kreis H, Martinez F, Thervet E, M?jean A, Lebret T, Legendre C, Delahousse M. Donor-estimated GFR as an appropriate criterion for allocation of ECD kidneys into single or dual kidney transplantation. Am J Transplant. 2009 Nov; 9(11):2542-51.
Score: 0.067
-
Loupy A, Suberbielle-Boissel C, Hill GS, Lefaucheur C, Anglicheau D, Zuber J, Martinez F, Thervet E, M?jean A, Charron D, Duong van Huyen JP, Bruneval P, Legendre C, Nochy D. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant. 2009 Nov; 9(11):2561-70.
Score: 0.067
-
Zafrani L, Truffaut L, Kreis H, Etienne D, Rafat C, Lechaton S, Anglicheau D, Zuber J, Ciroldi M, Thervet E, Snanoudj R, Mamzer MF, Martinez F, Timsit MO, Bergougnoux L, Legendre C. Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective study. Am J Transplant. 2009 Aug; 9(8):1816-25.
Score: 0.066
-
Snanoudj R, Martinez F, Sberro Soussan R, Thervet E, Legendre C. [Screening biopsies in kidney transplantation: from subclinical acute rejection to chronic allograft lesions]. Nephrol Ther. 2008 Oct; 4 Suppl 3:S192-9.
Score: 0.063
-
Anglicheau D, Loupy A, Lefaucheur C, Pessione F, L?tourneau I, C?t? I, Gaha K, No?l LH, Patey N, Droz D, Martinez F, Zuber J, Glotz D, Thervet E, Legendre C. A simple clinico-histopathological composite scoring system is highly predictive of graft outcomes in marginal donors. Am J Transplant. 2008 Nov; 8(11):2325-34.
Score: 0.062
-
Zuber J, Anglicheau D, Elie C, Bererhi L, Timsit MO, Mamzer-Bruneel MF, Ciroldi M, Martinez F, Snanoudj R, Hiesse C, Kreis H, Eustache F, Laborde K, Thervet E, Legendre C. Sirolimus may reduce fertility in male renal transplant recipients. Am J Transplant. 2008 Jul; 8(7):1471-9.
Score: 0.061
-
Anglicheau D, Loupy A, Suberbielle C, Zuber J, Patey N, No?l LH, Cavalcanti R, Le Quintrec M, Audat F, M?jean A, Martinez F, Mamzer-Bruneel MF, Thervet E, Legendre C. Posttransplant prophylactic intravenous immunoglobulin in kidney transplant patients at high immunological risk: a pilot study. Am J Transplant. 2007 May; 7(5):1185-92.
Score: 0.056
-
Canaud G, Knebelmann B, Harris PC, Vrtovsnik F, Correas JM, Pallet N, Heyer CM, Letavernier E, Bienaim? F, Thervet E, Martinez F, Terzi F, Legendre C. Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease: What is the appropriate serum level? Am J Transplant. 2010 Jul; 10(7):1701-6.
Score: 0.018